Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia
about
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agentsDiscovery and development of the Polo-like kinase inhibitor volasertib in cancer therapyElevated monocyte phosphorylated p38 in nearby employees after a chemical explosionExpression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulationTargeted Therapy of FLT3 in Treatment of AML-Current Status and Future Directions.Finding New Order in Biological Functions from the Network Structure of Gene Annotations.Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemiaAnti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia.STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.Single-cell proteomics: potential implications for cancer diagnostics.Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cellsMesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular MechanismsDrug Repurposing for the Treatment of Acute Myeloid Leukemia.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis
P2860
Q24633763-E84320EA-8780-4F53-868D-B2775D96C41FQ26991736-E4344DA6-EEAC-4E26-8B7F-60AF44D70824Q28831248-5100FE1D-B014-4175-BEE9-7D6A37C1074AQ35550103-AC292BAB-F8F6-4D7F-BF33-2B82A0FCE616Q35750567-E97A5013-3627-48E0-B974-C835CBB7D713Q35847146-89AC6A11-0D34-44D4-82F7-25B2AFC7E627Q36413237-1492977A-28F1-4A58-911E-DEEF2FEEDF9EQ37603441-020BBEB3-5311-402C-9532-F70428704E99Q38265472-2E1BFC71-C0BA-43B5-8857-4BBE27B9AA7AQ38376612-AD451B85-7C4E-46A6-B7B5-7AD5E402DC6FQ38741203-9689E919-8243-4AD6-A247-6DDEEBB9B3E7Q41625772-868A1FFA-7DE2-4399-89B5-8B079F576FADQ42262053-C66827D3-C717-4688-915D-4B323D71F5CFQ47094576-DAEAEB8A-B4EF-4937-949E-12E0D9AA2865Q51102707-6C20065A-32A4-41FD-86A4-FBB383B485A8Q58739036-13E44F10-B644-4145-8776-E6718A772CF0
P2860
Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Specific cellular signal-trans ...... line in acute myeloid leukemia
@ast
Specific cellular signal-trans ...... line in acute myeloid leukemia
@en
type
label
Specific cellular signal-trans ...... line in acute myeloid leukemia
@ast
Specific cellular signal-trans ...... line in acute myeloid leukemia
@en
prefLabel
Specific cellular signal-trans ...... line in acute myeloid leukemia
@ast
Specific cellular signal-trans ...... line in acute myeloid leukemia
@en
P2093
P2860
P356
P1433
P1476
Specific cellular signal-trans ...... line in acute myeloid leukemia
@en
P2093
J Skavland
K Hadziavdic
K M Jørgensen
O Bruserud
P2860
P2888
P356
10.1038/BCJ.2011.2
P577
2011-02-11T00:00:00Z
P5875
P6179
1026529812